Continuing Medical Education
Practicing ophthalmologists who care for patients with corneal-related conditions.
- Improve diagnostic skills, discuss treatment options, and integrate updated protocols related to ocular infections
- Compare and contrast lamellar and endothelial keratoplasty techniques, and implement surgical technique modifications as necessary to improve outcomes
- Explain current research related to the etiology and treatment of ocular surface diseases
- Describe current issues affecting global eye health and eye banking
- Implement strategies to identify and efficiently manage patients with ocular surface disease/dry eye disease
- Analyze the indications and surgical techniques for newer forms of lamellar keratoplasty
The American Society of Cataract and Refractive Surgery is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ASCRS takes responsibility for the content, quality and scientific integrity of the CME activity.
The American Society of Cataract and Refractive Surgery designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All CME activities approved for AMA PRA Category 1 Credits™ are valid for recognition by the European Accreditation Council for Continuing Medical Education (EACCME). Physicians not licensed in the U.S. who participate in this CME activity are eligible for AMA PRA Category 1 Credits™.
Claim CME/CE Credits
Attendees can evaluate the 2021 ASCRS Cornea Day Program online through the Claim CME/CE Credit Stations. When the evaluation is complete, a copy of the certificate for continuing education credits/hours for that day can be printed. If attendees do not complete the evaluation during the meeting, they will have the opportunity to complete them at home.
Notice About Off-Label Use Presentations
The ASCRS Annual Meeting may include presentations on drugs or devices or uses of drugs or devices that may not have been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice.
ASCRS is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations of off-label uses, does not imply an endorsement by ASCRS of the uses, products or techniques presented.